N-1-methylnicotinamide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameN-1-methylnicotinamide
Drug Alias Name1-methylnicotinamide cationTrigonellinamide1-MNATRIA 662MNA +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors agonists
TargetsNicotinic receptors
Therapy Area/IndicationsHypertriglyceridemiaHyperlipidemiasHyperlipidemia, Familial Combined
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTechnical University Munich
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCortria CorporationMontreal Heart InstitutePharmena North America
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHyperlipidemiasHyperlipidemia, Familial Combined

Other Information

ATC CodeN/A
Related LinksN/A